Human Microbiota in Esophageal Adenocarcinoma: Pathogenesis, Diagnosis, Prognosis and Therapeutic Implications

Overview

Journal Front Microbiol

Specialty Microbiology

Date 2022 Feb 7

PMID 35126331

Authors

Wanyue Dan

Lihua Peng

Bin Yan

Zhengpeng Li

Fei Pan

Affiliations

Soon will be listed here.

Abstract

Esophageal adenocarcinoma (EAC) is one of the main subtypes of esophageal cancer. The incidence rate of EAC increased progressively while the 5-year relative survival rates were poor in the past two decades. The mechanism of EAC has been studied extensively in relation to genetic factors, but less so with respect to human microbiota. Currently, researches about the relationship between EAC and the human microbiota is a newly emerging field of study. Herein, we present the current state of knowledge linking human microbiota to esophageal adenocarcinoma and its precursor lesion-gastroesophageal reflux disease and Barrett's esophagus. There are specific human bacterial alternations in the process of esophageal carcinogenesis. And bacterial dysbiosis plays an important role in the process of esophageal carcinogenesis inflammation, microbial metabolism and genotoxicity. Based on the human microbiota alternation in the EAC cascade, it provides potential microbiome-based clinical application. This review is focused on novel targets in prevention, diagnosis, prognosis, and therapy for esophageal adenocarcinoma.

Citing Articles

Is infection protective against esophageal cancer?.

Maity R, Dhali A, Biswas J World J Gastroenterol. 2024; 30(38):4168-4174.

PMID: 39493327 PMC: 11525877. DOI: 10.3748/wjg.v30.i38.4168.

Predicting the potential deterioration of Barrett's esophagus based on gut microbiota: a Mendelian randomization analysis.

Li C, Shu P, Shi T, Chen Y, Mei P, Zhang Y Mamm Genome. 2024; 35(3):399-413.

PMID: 38886201 DOI: 10.1007/s00335-024-10042-7.

Salivary microbiome is associated with the response to chemoradiotherapy in initially inoperable patients with esophageal squamous cell carcinoma.

He Y, Li X, Hu A, Qian D J Oral Microbiol. 2024; 16(1):2359887.

PMID: 38813524 PMC: 11134033. DOI: 10.1080/20002297.2024.2359887.

Decoding spatiotemporal transcriptional dynamics and epithelial fibroblast crosstalk during gastroesophageal junction development through single cell analysis.

Kumar N, Prakash P, Wentland C, Kurian S, Jethva G, Brinkmann V Nat Commun. 2024; 15(1):3064.

PMID: 38594232 PMC: 11004180. DOI: 10.1038/s41467-024-47173-z.

Prebiotic proanthocyanidins inhibit bile reflux-induced esophageal adenocarcinoma through reshaping the gut microbiome and esophageal metabolome.

Weh K, Howard C, Zhang Y, Tripp B, Clarke J, Howell A JCI Insight. 2024; 9(6).

PMID: 38329812 PMC: 11063939. DOI: 10.1172/jci.insight.168112.

References

Macfarlane S, Furrie E, Macfarlane G, Dillon J . Microbial colonization of the upper gastrointestinal tract in patients with Barrett's esophagus. Clin Infect Dis. 2007; 45(1):29-38. DOI: 10.1086/518578. View

Akiyama Y, Sasaki A, Fujii Y, Fujisawa R, Sasaki N, Nikai H . Efficacy of enhanced prehabilitation for patients with esophageal cancer undergoing esophagectomy. Esophagus. 2020; 18(1):56-64. DOI: 10.1007/s10388-020-00757-2. View

Amir I, Konikoff F, Oppenheim M, Gophna U, Half E . Gastric microbiota is altered in oesophagitis and Barrett's oesophagus and further modified by proton pump inhibitors. Environ Microbiol. 2013; 16(9):2905-14. DOI: 10.1111/1462-2920.12285. View

Mozaffari Namin B, Mehdi Soltan Dallal M, Ebrahimi Daryani N . The Effect of Campylobacter concisus on Expression of IL-18, TNF-α and p53 in Barrett's Cell Lines. Jundishapur J Microbiol. 2016; 8(12):e26393. PMC: 4744463. DOI: 10.5812/jjm.26393. View

Zhou J, Shrestha P, Qiu Z, Harman D, Teoh W, Al-Sohaily S . Distinct Microbiota Dysbiosis in Patients with Non-Erosive Reflux Disease and Esophageal Adenocarcinoma. J Clin Med. 2020; 9(7). PMC: 7408827. DOI: 10.3390/jcm9072162. View

Dominguez-Bello M, Godoy-Vitorino F, Knight R, Blaser M . Role of the microbiome in human development. Gut. 2019; 68(6):1108-1114. PMC: 6580755. DOI: 10.1136/gutjnl-2018-317503. View

Malfertheiner P, Kandulski A, Venerito M . Proton-pump inhibitors: understanding the complications and risks. Nat Rev Gastroenterol Hepatol. 2017; 14(12):697-710. DOI: 10.1038/nrgastro.2017.117. View

Wilson M, Jiang Y, Villalta P, Stornetta A, Boudreau P, Carra A . The human gut bacterial genotoxin colibactin alkylates DNA. Science. 2019; 363(6428). PMC: 6407708. DOI: 10.1126/science.aar7785. View

. Structure, function and diversity of the healthy human microbiome. Nature. 2012; 486(7402):207-14. PMC: 3564958. DOI: 10.1038/nature11234. View

10.

Snider E, Compres G, Freedberg D, Khiabanian H, Nobel Y, Stump S . Alterations to the Esophageal Microbiome Associated with Progression from Barrett's Esophagus to Esophageal Adenocarcinoma. Cancer Epidemiol Biomarkers Prev. 2019; 28(10):1687-1693. PMC: 6774849. DOI: 10.1158/1055-9965.EPI-19-0008. View

11.

ORorke M, Ellison M, Murray L, Moran M, James J, Anderson L . Human papillomavirus related head and neck cancer survival: a systematic review and meta-analysis. Oral Oncol. 2012; 48(12):1191-201. DOI: 10.1016/j.oraloncology.2012.06.019. View

12.

Rajendra S, Xuan W, Merrett N, Sharma P, Sharma P, Pavey D . Survival Rates for Patients With Barrett High-grade Dysplasia and Esophageal Adenocarcinoma With or Without Human Papillomavirus Infection. JAMA Netw Open. 2019; 1(4):e181054. PMC: 6324261. DOI: 10.1001/jamanetworkopen.2018.1054. View

13.

Yang L, Chaudhary N, Baghdadi J, Pei Z . Microbiome in reflux disorders and esophageal adenocarcinoma. Cancer J. 2014; 20(3):207-10. PMC: 4120752. DOI: 10.1097/PPO.0000000000000044. View

14.

. The Integrative Human Microbiome Project. Nature. 2019; 569(7758):641-648. PMC: 6784865. DOI: 10.1038/s41586-019-1238-8. View

15.

Babar M, Ryan A, Anderson L, Segurado R, Turner G, Murray L . Genes of the interleukin-18 pathway are associated with susceptibility to Barrett's esophagus and esophageal adenocarcinoma. Am J Gastroenterol. 2012; 107(9):1331-41. DOI: 10.1038/ajg.2012.134. View

16.

Zhao Q, Yang T, Yan Y, Zhang Y, Li Z, Wang Y . Alterations of Oral Microbiota in Chinese Patients With Esophageal Cancer. Front Cell Infect Microbiol. 2020; 10:541144. PMC: 7609410. DOI: 10.3389/fcimb.2020.541144. View

17.

Martinon P, Fraticelli L, Giboreau A, Dussart C, Bourgeois D, Carrouel F . Nutrition as a Key Modifiable Factor for Periodontitis and Main Chronic Diseases. J Clin Med. 2021; 10(2). PMC: 7827391. DOI: 10.3390/jcm10020197. View

18.

Ragin C, Taioli E . Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer. 2007; 121(8):1813-20. DOI: 10.1002/ijc.22851. View

19.

Munemoto M, Mukaisho K, Miyashita T, Oyama K, Haba Y, Okamoto K . Roles of the hexosamine biosynthetic pathway and pentose phosphate pathway in bile acid-induced cancer development. Cancer Sci. 2019; 110(8):2408-2420. PMC: 6676276. DOI: 10.1111/cas.14105. View

20.

Kageyama S, Takeshita T, Takeuchi K, Asakawa M, Matsumi R, Furuta M . Characteristics of the Salivary Microbiota in Patients With Various Digestive Tract Cancers. Front Microbiol. 2019; 10:1780. PMC: 6688131. DOI: 10.3389/fmicb.2019.01780. View